The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of dose dense (weekly) paclitaxel with pembrolizumab (MK-3475) in platinum-resistant recurrent ovarian cancer.
 
Robert Michael Wenham
Honoraria - Genentech; Janssen Biotech; Lilly
Consulting or Advisory Role - Genentech; Tesaro
Speakers' Bureau - Genentech; Janssen Biotech
Research Funding - Merck; Tesaro
 
Sachin M. Apte
No Relationships to Disclose
 
Mian M. Shahzad
No Relationships to Disclose
 
Jae K Lee
No Relationships to Disclose
 
Denise Dorman
No Relationships to Disclose
 
Hye Sook Chon
No Relationships to Disclose